Mode
Text Size
Log in / Sign up
N/A N=212 Randomized Diagnostic

Guidance of Ultrasound in Intensive Care to Direct Euvolemia

Acute Kidney Injury

Enrolled (actual)
212
Serious AEs
9.3%
Results posted
Apr 2024
Primary outcome: Primary: Number of Acute Kidney Injury (AKI)-Free Days — 1; 1 Days

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Serial ultrasound assessments for GDT (Diagnostic_test); Usual care (Diagnostic_test)
Age
Pediatric, Adult, Older Adult · 16+ yrs
Sex
All
Sponsor
The University of Texas Health Science Center, Houston
Primary completion
Jun 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Acute Kidney Injury (AKI)-Free Days
1; 1
PRIMARY
Number of Participants Who Receive 3 or More Ultrasound Volume Assessments
7; 0
SECONDARY
Number of Participants With Acute Kidney Injury (AKI)
115; 119
SECONDARY
Stage of Acute Kidney Injury (AKI)
67; 64; 32; 37; 16; 18
SECONDARY
Number of Participants With Need for Renal Replacement Therapy
16; 18
SECONDARY
Quantity of Fluids Administered
1215; 572
SECONDARY
Quantity of Fluids Administered
1215; 572
SECONDARY
Type of Fluids Administered
SECONDARY
Type of Fluids Administered
SECONDARY
Quantity of Diuretics Administered
0; 0
SECONDARY
Quantity of Diuretics Administered
0; 0
SECONDARY
Time to Lactate Normalization
SECONDARY
Time to Creatinine Concentration <1.5 mg/dL or to Prehospital Baseline
SECONDARY
Time to Base Excess Normalization
SECONDARY
Number of Ventilator-free Days
29; 29
SECONDARY
Number of ICU-free Days
26; 26

Summary

The purpose of this study is to assess the effectiveness of routine ultrasound assessments of volume status and fluid responsiveness for goal-directed therapy (GDT)-based fluid resuscitation in reducing acute kidney injury (AKI) incidence and duration in trauma patients in a teaching institution.

Eligibility Criteria

Inclusion Criteria

  • Injured patients that are admitted to the trauma ICU

Exclusion Criteria

  • Incarceration
  • Pregnancy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03938038). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search